Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Induced hypertension for preventing complications of delayed cerebral ischaemia in aneurysmal subarachnoid haemorrhage

Information

DOI:
https://doi.org/10.1002/14651858.CD012842Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 14 November 2017see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Stroke Group

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Frank Van Haren

    Correspondence to: ICU, Canberra Hospital, Woden, Australia

    [email protected]

    Australian National University, Canberra, Australia

    University of Canberra, Canberra, Australia

  • Peter Velloza

    ICU, Canberra Hospital, Woden, Australia

  • Sean Chan

    ICU, Canberra Hospital, Woden, Australia

  • Peter Mews

    Department of Neurosurgery, Canberra Hospital, Woden, Australia

  • Christian J Lueck

    Australian National University, Canberra, Australia

    Department of Neurology, Canberra Hospital, Woden, Australia

Contributions of authors

FvH wrote the protocol, which was reviewed by PV, SC, PM, and CJL.

Declarations of interest

Frank Van Haren: none known.
Peter Velloza: none known.
Sean Chan: none known.
Peter Mews: none known.
Christian J Lueck: none known.

Acknowledgements

We thank Hazel Fraser, Managing Editor, and Joshua Cheyne, Information Specialist, for help with the development of this protocol; and the Cochrane Stroke Group editors Peter Langhorne, Rustam Al‐Shahi Salman, and Valentina Assi for their comments during the editorial process.

Version history

Published

Title

Stage

Authors

Version

2017 Nov 14

Induced hypertension for preventing complications of delayed cerebral ischaemia in aneurysmal subarachnoid haemorrhage

Protocol

Frank Van Haren, Peter Velloza, Sean Chan, Peter Mews, Christian J Lueck

https://doi.org/10.1002/14651858.CD012842

Table 1. 'Summary of findings' table template

Induced hypertension versus no induced hypertension in people with aneurysmal subarachnoid haemorrhage (SAH)

Participants: people with aneurysmal subarachnoid haemorrhage documented by CT scan, who underwent treatment of the aneurysm (either surgical clipping or intraluminal coiling) and entered the trial within 2 weeks after the SAH

Setting: hospital

Intervention: induced hypertension

Comparison: without induced hypertension

Outcomes

Absolute risk

Comparative risk (95% CI)

Relative effect (95% CI)

Number of participants

(studies)

Quality of the evidence

(GRADE)

Comments

Unfavourable outcome1 (90 days)

Death (any cause) at 90 days; in the intensive care unit; in hospital

Unfavourable outcome1 (6 months)

Incidence of DCI and vasospasm‐related complications within 3 weeks of the SAH

Cerebral infarction2

Re‐bleeding3

Complications of intervention4

Physiological outcome measures5

Abbreviations: CT scan: computed tomography scan; MRI scan: magnetic resonance imaging scan; SAH: subarachnoid haemorrhage; DCI: delayed cerebral ischaemia; CI: confidence interval; RR: risk ratio; GRADE: Grading of Recommendations Assessment, Development and Evaluation; MAP: mean arterial blood pressure.

1Unfavourable outcome: death, persistent vegetative state, or severe disability (modified Rankin Scale (mRS) score 4 to 6, Extended Glasgow Outcome Scale (GOSE) 4 to 6 or equivalent) at 90 days after SAH.
2Established cerebral infarction at any time within 90 days after SAH, confirmed radiologically by CT or MRI scan.
3Recurrent haemorrhage during the intervention or within 24 hours after the intervention.
4Complications of intervention, defined as a clinical deterioration observed during the intervention or within 24 hours after the intervention. These complications include arrhythmias, cardiac ischaemia, mesenteric ischaemia, digital ischaemia, and haemorrhagic stroke unrelated to the primary disease.
5Physiological outcome measures during the intervention or within 24 hours after the intervention. These include cerebral blood flow (CBF), cerebral perfusion pressure, cerebral tissue oxygenation, cerebral microdialysis, cardiac output and mean arterial blood pressure (MAP).

Figures and Tables -
Table 1. 'Summary of findings' table template